Next-Generation Sequencing (NGS) is the sequencing of thousands and millions of DNA molecule at the same time. The powerful platform is transforming medical domains, such as genetic diseases, personalized medications, and clinical diagnostics by providing high throughput with abilities to sequence multiple people simultaneously. Several types of next-generation sequencing machines have been launched in the previous decade, which permit huge parallel sequencing reactions. Every machine efficiently analyzes billions of sequencing reactions altogether. Even though different machines operate with different technical capabilities, they share a few common characteristics.
Market Industry Reports (MIR) has published a new report titled "Next-generation sequencing (NGS) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global Next-Generation Sequencing (NGS) market is estimated to be over US$ 4.0 Bn in 2017. It is anticipated to grow at a CAGR of 18.8% from 2019 to 2030.Major Key Players of the Next-generation sequencing (NGS) Market are:
Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.
No comments:
Post a Comment